Tyrosine hydroxylase deficiency with severe clinical course

Molecular Genetics and Metabolism

Volumn 97, Issue 1, 2009, Pages 18-20

  Zafeiriou, D I ^a   Willemsen, M A ^b   Verbeek, M M ^b   Vargiami, E ^a   Ververi, A ^a   Wevers, R ^b  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Dopa non responsive dystonia; Infantile encephalopathy; Tyrosine hydroxylase deficiency

Indexed keywords

CLONAZEPAM; LAMOTRIGINE; LEVODOPA; NEUROTRANSMITTER; PROLACTIN; SELEGILINE; TYROSINE 3 MONOOXYGENASE;

ADD ON THERAPY; ARTICLE; AUTOSOMAL RECESSIVE DISORDER; CASE REPORT; CEREBROSPINAL FLUID CYTOLOGY; CHILD; CHOREOATHETOSIS; CLINICAL FEATURE; DISEASE COURSE; DISEASE SEVERITY; DRUG DOSE REDUCTION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; DYSTONIA; DYSTONIC DISORDER; ENZYME DEFICIENCY; GROWTH RETARDATION; HUMAN; HYPERKINESIA; HYPOKINESIA; INFANTILE SPASM; MALE; MISSENSE MUTATION; MUSCLE HYPOTONIA; OCULOGYRIC CRISIS; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; SCHOOL CHILD; TREATMENT RESPONSE; TREMOR; TYROSINE HYDROXYLASE DEFICIENCY;

CASE-CONTROL STUDIES; CATECHOLAMINES; CHILD; CHILD, PRESCHOOL; HUMANS; INFANT; MALE; TYROSINE 3-MONOOXYGENASE;

EID: 63449095782     PISSN: 10967192     EISSN: 10967206     Source Type: Journal    
DOI: 10.1016/j.ymgme.2009.02.001     Document Type: Article

References (9)

1. Wevers R.A., de Rijk-van Andel J.F., Brautigam C., Geurtz B., van den Heuvel L.P., Steenbergen-Spanjers G.C., Smeitink J.A., Hoffmann G.F., and Gabreels F.J. A review of biochemical and molecular genetic aspects of tyrosine hydroxylase deficiency including a novel mutation (291delC). J. Inherit. Metab. Dis. 22 (1999) 364-373
2. Hoffmann G.F., Assmann B., Bräutigam C., Dionisi-Vici C., Häussler M., de Klerk J.B., Naumann M., Steenbergen-Spanjers G.C., Strassburg H.M., and Wevers R.A. Tyrosine hydroxylase deficiency causes progressive encephalopathy and dopa-non-responsive dystonia. Ann. Neurol. 54 (2003) 56-65
3. Lüdecke B., Knappskog P.M., Clayton P.T., Surtees R.A., Clelland J.D., Heales S.J., Brand M.P., Bartholomé K., and Flatmark T. Recessively inherited l-dopa-responsive parkinsonism in infancy caused by a point mutation (L205P) in the tyrosine hydroxylase gene. Hum. Mol. Genet. 5 (1996) 1023-1028
4. Knappskog P.M., Flatmark T., Mallet J., Lüdecke B., and Bartholome K. Recessive inherited l-dopa-responsive dystonia caused by a point mutation (Q381K) in the tyrosine hydroxylase gene. Hum. Mol. Genet. 4 (1995) 1209-1212
5. Zhou Q.-Y., Qualfe C.J., and Palmiter R.D. Targeted disruption of the tyrosine hydroxylase gene reveals that catecholamines are required for mouse fetal development. Nature 374 (1995) 640-643
6. Van den Heuvel L.P., Luiten B., Smeitink J.A., de Rijk-van Andel J.F., Hyland K., Steenbergen-Spanjers G.C., Janssen R.J., and Wevers R.A. A common point mutation in the tyrosine hydroxylase gene in autosomal recessive l-dopa-responsive dystonia in the Dutch population. Hum. Genet. 102 (1998) 644-646
7. Müller L.B., Romstad A., Paulsen M., Hougaard P., Ormazabal A., Pineda M., Blau N., Güttler F., and Artuch R. Pre- and post-natal diagnosis of tyrosine hydroxylase deficiency. Prenat. Diagn. 25 (2005) 671-675
8. Ribases M., Serrano M., Fernandez-Alvarez E., Pahisa S., Ormazabal A., Garcia-Cazorla A., Perez-Duenas B., Campistol J., Artuch R., and Cormand B. A homozygous tyrosine hydroxylase gene promoter mutation in a patient with dopa-responsive encephalopathy: clinical biochemical and genetic analysis. Mol. Genet. Metab. 92 (2007) 274-277
9. Giovanniello T., Leuzzi V., Carducci C., Sabato M.L., Artiola C., Santagata S., Pozzessere S., and Antonozzi I. Tyrosine hydroxylase deficiency presenting with a biphasic clinical course. Neuropediatrics 37 (2007) 213-215